Literature DB >> 10997622

Physiopathology of prolactin secretion in obesity.

P G Kopelman1.   

Abstract

In many species prolactin is of biological importance and has a major role in determining the deposition and mobilization of fat. In human physiology, outside pregnancy, prolactin secretion is altered by increasing body weight in both children and adults. Prolactin in this circumstance appears to be marker of hypothalamic-pituitary function: the prolactin response to insulin-hypoglycaemia, thyrotrophin releasing hormone stimulation and other stimulatory factors may be diminished. In addition, obesity alters the 24h spontaneous release of prolactin with a generalised dampening of release. A number of explanations have been given as possible causes for these alterations, but it seems likely that they reflect obesity per se and are associated with hyperinsulinaemia. Weight reduction, with accompanying decrease in plasma insulin levels, leads to a normalization of prolactin responses in most, but not all, circumstances. To date, no molecular basis has been identified which links prolactin with increasing body fatness, weight and appetite: new data suggests a possible link in obese men between fasting plasma prolactin and leptin concentrations.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10997622     DOI: 10.1038/sj.ijo.0801291

Source DB:  PubMed          Journal:  Int J Obes Relat Metab Disord


  10 in total

1.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

Review 2.  [Prevention of coronary artery disease].

Authors:  M Sandri; S Gielen; G Schuler
Journal:  Internist (Berl)       Date:  2008-02       Impact factor: 0.743

3.  Basal serum prolactin levels in obesity--unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss.

Authors:  Barbara Ernst; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2009-05-09       Impact factor: 4.129

4.  Bromocriptine improves glucose tolerance independent of circadian timing, prolactin, or the melanocortin-4 receptor.

Authors:  Sarah N Framnes-DeBoer; Ellen Bakke; Suma Yalamanchili; Hannah Peterson; Darleen A Sandoval; Randy J Seeley; Deanna M Arble
Journal:  Am J Physiol Endocrinol Metab       Date:  2019-12-03       Impact factor: 4.310

Review 5.  The role of prolactin in andrology: what is new?

Authors:  Giulia Rastrelli; Giovanni Corona; Mario Maggi
Journal:  Rev Endocr Metab Disord       Date:  2015-09       Impact factor: 6.514

6.  Effectiveness of a new approach for exclusive breastfeeding counselling on breastfeeding prevalence, infant growth velocity and postpartum weight loss in overweight or obese women: protocol for a randomized controlled trial.

Authors:  Fanny Aldana-Parra; Gilma Olaya; Mary Fewtrell
Journal:  Int Breastfeed J       Date:  2020-01-06       Impact factor: 3.461

7.  Repurposing prolactin as a promising immunomodulator for the treatment of COVID-19: Are common Antiemetics the wonder drug to fight coronavirus?

Authors:  Amarnath Sen
Journal:  Med Hypotheses       Date:  2020-08-24       Impact factor: 1.538

Review 8.  Metabolic effects of prolactin and the role of dopamine agonists: A review.

Authors:  Polly Kirsch; Jessica Kunadia; Shruti Shah; Nidhi Agrawal
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-30       Impact factor: 6.055

9.  Obstructive sleep apnea and hormones - a novel insight.

Authors:  Marek Ruchała; Barbara Bromińska; Ewa Cyrańska-Chyrek; Barbara Kuźnar-Kamińska; Magdalena Kostrzewska; Halina Batura-Gabryel
Journal:  Arch Med Sci       Date:  2016-08-05       Impact factor: 3.318

10.  Factors associated with the level of prolactin in patients under remission from Alcohol Use Disorder: A gender perspective.

Authors:  Susmita Pandey; Ingeborg Bolstad; Lars Lien; Jørgen G Bramness
Journal:  Neuropsychopharmacol Rep       Date:  2021-05-07
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.